Literature DB >> 17997337

Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).

Nele Friedrich1, Dietrich Alte, Henry Völzke, Elisabeth Spilcke-Liss, Jan Lüdemann, Markus M Lerch, Thomas Kohlmann, Matthias Nauck, Henri Wallaschofski.   

Abstract

OBJECTIVE: Insulin-like growth factor I (IGF-1), which is mostly carried by IGF binding protein 3 (IGFBP-3), mediates endocrine actions of growth hormone and represents an important prognostic factor for systemic diseases. The main objectives of the present study were (1) to calculate age- and sex-specific reference values for serum IGF-1 and IGFBP-3 levels using the Gaussian mean+/-1.96 *standard deviation method and the quantile regression method and (2) to perform a comparison of the results from both statistical methods.
DESIGN: Cross-sectional study (Study of Health in Pomerania). The study population included 2499 men and women aged 20-79 years.
METHODS: Serum IGF-1 and IGFBP-3 levels were determined by chemiluminescence immunoassays. Linear and quantile regressions were performed to calculate age- and sex-related reference ranges.
RESULTS: Both statistical methods generated different results: The reference ranges based on linear regression identified 43 (1.7%) subjects with serum IGF-1 levels and 99 (4.0%) subjects with serum IGFBP-3 levels outside the reference range. Using quantile regression, 117 (4.7%) or 118 subjects (4.7%) with serum IGF-1 or IGFBP-3 levels outside the range were detected, respectively.
CONCLUSION: The present study established age- and sex-specific reference ranges for serum IGF-1 and IGFBP-3 levels. Quantile regression should be preferred to calculate reference ranges because a better concordance to original data is possible due to no distribution assumption are required and the robustness against outliers is given.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997337     DOI: 10.1016/j.ghir.2007.09.005

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  20 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells.

Authors:  David D New; Karen Block; Basant Bhandhari; Yves Gorin; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

3.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

4.  Cognitive response to estradiol in postmenopausal women is modified by high cortisol.

Authors:  Laura D Baker; Sanjay Asthana; Brenna A Cholerton; Charles W Wilkinson; Stephen R Plymate; Pattie S Green; George R Merriam; Mark A Fishel; G Stennis Watson; Monique M Cherrier; Monica L Kletke; Pankaj D Mehta; Suzanne Craft
Journal:  Neurobiol Aging       Date:  2011-08-19       Impact factor: 4.673

5.  Epidemiologic survey: reference ranges of serum insulin-like growth factor 1 levels in Caucasian adult population with immunoradiometric assay.

Authors:  Fahri Bayram; Vedia Tonyukuk Gedik; Özgür Demir; Ahmet Kaya; Kürşat Gündoğan; Rıfat Emral; Ahmet Öztürk; Ali Rıza Uysal; Demet Çorapçıoğlu
Journal:  Endocrine       Date:  2011-05-03       Impact factor: 3.633

6.  Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.

Authors:  M-C Lu; C-L Yu; H-C Chen; H-C Yu; H-B Huang; N-S Lai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

7.  Enhancing engineered vascular networks in vitro and in vivo: The effects of IGF1 on vascular development and durability.

Authors:  Claudia C Friedrich; Yunfeng Lin; Alexander Krannich; Yinan Wu; Joseph P Vacanti; Craig M Neville
Journal:  Cell Prolif       Date:  2017-11-07       Impact factor: 6.831

8.  Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels.

Authors:  Rong Yuan; Shirng-Wern Tsaih; Stefka B Petkova; Caralina Marin de Evsikova; Shuqin Xing; Michael A Marion; Molly A Bogue; Kevin D Mills; Luanne L Peters; Carol J Bult; Clifford J Rosen; John P Sundberg; David E Harrison; Gary A Churchill; Beverly Paigen
Journal:  Aging Cell       Date:  2009-04-09       Impact factor: 9.304

9.  Insulin-like Growth Factor 1 and Adiponectin and Associations with Muscle Deficits, Disease Characteristics, and Treatments in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Joan Marie Von Feldt; Sogol Mostoufi-Moab; Woojin Kim; Elena Taratuta; Mary B Leonard
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

10.  Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.

Authors:  Mahmoud A Pouladi; Yuanyun Xie; Niels Henning Skotte; Dagmar E Ehrnhoefer; Rona K Graham; Jeong Eun Kim; Nagat Bissada; X William Yang; Paolo Paganetti; Robert M Friedlander; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2010-01-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.